Related Experiment Video
Updated: Apr 4, 2026

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
ConTour: Data-Driven Exploration of Multi-Relational Datasets for Drug Discovery
IEEE Transactions on Visualization and Computer Graphics
|September 11, 2015
Summary
ConTour is a new visual analytics tool that helps scientists explore complex drug discovery data. It enables rapid evaluation of compounds by visualizing relationships across multiple datasets.
Area of Science:
- Bioinformatics
- Drug Discovery
- Data Visualization
Background:
- Drug discovery relies heavily on analyzing large, interconnected datasets.
- Current tools lack effective methods for exploring multi-relational biological and chemical data.
- Efficiently evaluating compound efficacy and safety is a significant challenge.
Purpose of the Study:
- To introduce ConTour, an interactive visual analytics technique for exploring complex, multi-relational datasets in drug discovery.
- To provide biologists and chemists with a tool to quickly assess potential drug compounds.
- To address the limitations of existing data analysis tools in this domain.
Main Methods:
- ConTour presents datasets as columns, with relationships visualized through interactive selection and re-sorting.
- Employs advanced sorting strategies (connectivity, uniqueness, attributes) and interactive column nesting.
- Features filters for drilling down into data and detail views for multi-dataset item examination.
Main Results:
- ConTour facilitates the exploration of complex relationships within large-scale datasets.
- Interactive features enable users to identify interesting compounds based on various criteria.
- The system effectively visualizes item attributes and connection strengths across datasets.
Conclusions:
- ConTour offers a novel solution for interactive visual analysis of multi-relational data in drug discovery.
- The technique empowers scientists to explore and evaluate compounds more efficiently.
- Case studies with chemical biologists confirm ConTour's utility in understanding compound effects and mechanisms.
Related Concept Videos
Drug Discovery: Overview
13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Quantitative Aspects of Drug-Receptor Interaction
2.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.2K
Structure-Activity Relationships and Drug Design
2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
404
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
404
Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Drug-Receptor Bonds
5.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
5.3K

